Buoy Review
Best for: GLP-1-companion electrolyte supplement
Buoy is a liquid electrolyte supplement positioned as a hydration enhancer for active lifestyles, low-carb diets, and GLP-1 users — populations that lose electrolytes faster and benefit from supplemental sodium, potassium, and magnesium. Listed here as a GLP-1 companion product because electrolyte loss is a documented side effect of rapid GLP-1-mediated weight loss.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Buoy is a solid telehealth option with balanced features and pricing.
Score Breakdown
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Monthly subscription (preliminary) | brand | $30 |
✓ Pros
- •Liquid format mixes into any beverage — easier compliance than electrolyte powders
- •Sugar-free / no artificial sweeteners (per brand positioning)
- •Useful adjunct for GLP-1 patients who experience electrolyte loss from reduced appetite and rapid weight loss
✗ Cons
- •Stub entry — exact pricing, ingredient panel per serving, and clinical positioning need a YMYL verification pass
- •Confidence is LOW until that pass is done
- •Not a substitute for prescription electrolyte management in clinically significant cases
Ready to start with Buoy?
Starting at $30/month. See current pricing and start your free consultation.
Sources & methodology
Our Buoy review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of April 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
Alternatives to Buoy
BetterBrand
Best for: pending product verification
Editorial score · methodology
fatty15
Best for: single-ingredient C15:0 longevity supplement
Editorial score · methodology
Gruns Greens
Best for: daily-multivitamin gummy as a GLP-1 nutrition adjunct
Editorial score · methodology
Frequently Asked Questions
Ready to start with Buoy?
Starting at $30/month. See current pricing and start your free consultation.